drugset / Trial / NCT05942820
The Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of BWC0977 in Healthy Adult Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the safety, tolerability and pharmacokinetics of single and multiple intravenous doses of BWC0977 when administered to healthy adult volunteers.
Timeline
- Start
- 2023-08-30
- Primary completion
- 2024-01-30
- Completion
- 2024-02-15
Outcome
Outcome not reported
Stopped: “CMC challenges”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BWC0977 | Unknown | 240 mg | Intravenous |
| Subject | BWC0977 | Unknown | 750 mg | Intravenous |
| Subject | BWC0977 | Unknown | 1000 mg | Intravenous |
| Subject | BWC0977 | Unknown | 1250 mg | Intravenous |
| Subject | BWC0977 | Unknown | 1500 mg | Intravenous |